沃森生物：子公司收到政府补助资金8900万元

Core Viewpoint - Watson Bio announced a government subsidy of 89 million yuan, which significantly impacts its financials, particularly its net profit and net assets [1] Group 1: Government Subsidy - Watson Bio's subsidiary received a government subsidy of 89 million yuan on October 29, 2025 [1] - The subsidy includes 56.58 million yuan related to income, accounting for 39.8% of the company's audited net profit attributable to shareholders for the most recent fiscal year [1] - An additional 32.42 million yuan is related to assets, representing 0.34% of the company's audited net assets for the same period [1] Group 2: Revenue Composition - For the first half of 2025, Watson Bio's revenue composition was as follows: 94.82% from self-developed vaccines, 4.67% from intermediate products, 0.26% from other businesses, and 0.24% from service income [1] Group 3: Market Capitalization - As of the report, Watson Bio's market capitalization stands at 18.8 billion yuan [1]